Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Charities invest £4.2m for London biosciences hub

June 11, 2013 Research and Development, Sales and Marketing Biochemical Society, London hub, Society for General Microbiology, Society of Biology

A collective of five charitable societies have come together to create a new bioscience hub in central London. The offices …
News
angus_russell_questcor

Questcor hires Shire’s chief executive

June 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Questcor, Shire

Biopharma firm Questcor Pharmaceuticals has appointed the recently-retired chief executive of Shire to its Board of directors.   Angus Russell …
Appointment

Novartis works in MS switch

June 11, 2013 Research and Development, Sales and Marketing MS, Novartis, gilenya

Novartis’ oral MS drug Gilenya has been found to help multiple sclerosis (MS) patients who switch to it after taking …
News

High cure rate for Boehringer HCV drug

June 11, 2013 Research and Development, Sales and Marketing Boehringer Ingelheim, HCV

One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …
News
astrazeneca image

AstraZeneca to pay up to $1.2 billion for Pearl

June 10, 2013 Research and Development, Sales and Marketing AstraZeneca, COPD, pearl therapeutics

AstraZeneca is betting big on lung disease specialist Pearl Therapeutics as it looks to spend $1.2 billion to acquire the …
News
Vifor image

Working Life, Vifor Pharma, Derek Williams

June 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vifor pharma, Working Life, williams

How did you find your way into your current role? I began my career in the UK as a sales …
Feature
kim_sinil_4

Mirna appoints ex-Pfizer senior director

June 6, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, miRNA

Biotech firm Mirna Therapeutics has appointed Dr Sinil Kim as vice president of Oncology and chief medical officer. Kim will …
Appointment

Aveo to cut workforce after FDA knock-back

June 6, 2013 Research and Development, Sales and Marketing Aveo, FDA, cuts, tivozanib

Aveo will make major jobs cuts this year after news that a kidney cancer licence for its oncology drug tivozanib …
News

Novartis drug shows cancer promise

June 5, 2013 Research and Development, Sales and Marketing ASCO, Cancer, Novartis

A Novartis drug which has been given breakthrough therapy designation by the FDA has demonstrated early promise in patients with …
News
GSK image

GSK licences RA drug

June 5, 2013 Research and Development, Sales and Marketing GSK, RA, morphosys

GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …
News
astrazeneca image

AstraZeneca abandons late-stage RA drug

June 5, 2013 Research and Development, Sales and Marketing AstraZeneca, RA, Rigel

AstraZeneca is to exit development of a new rheumatoid arthritis drug, after Phase III trials produced disappointing results.The Anglo-Swedish firm …
News

Sanofi admits $285m failure

June 4, 2013 Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban

Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …
News
Boehringer image

NSCLC lift for Boehringer

June 4, 2013 Research and Development, Sales and Marketing Boehringer, NSCLC

Boehringer’s pipeline has been boosted with the news that its investigational oral triple angiokinase inhibitor nintedanib plus chemotherapy, extends the …
News
brent_lang

Vocera appoints president and chief executive

June 4, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brent Lang, Vocera

Healthcare comms firm Vocera Communications has announced Brent Lang’s appointment as president and chief executive officer to the firm and …
Appointment
Howe and Willetts image

UK government cautious on trial transparency

June 4, 2013 Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency

Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026